Pacific Biosciences of California, Inc.PACBNASDAQ
Loading
EBITDA as a percentage of revenue
Percentile
P57
Within normal range
vs 5Y Ago
-2x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | -100.17% | +36.5% |
| 2024 | -157.63% | -16.6% |
| 2023 | -135.21% | +38.5% |
| 2022 | -219.98% | -14.5% |
| 2021 | -192.13% | -488.9% |
| 2020 | 49.40% | +162.7% |
| 2019 | -78.75% | +33.4% |
| 2018 | -118.18% | -36.7% |
| 2017 | -86.47% | -16.6% |
| 2016 | -74.15% | - |